Nov 07,2018

Diabeloop obtains CE marking and launches new round of funding

Diabeloop announced today it has received the CE marking for the DBLG1™, its innovative technological solution to radically improve quality of life for T1D patients through better blood sugar management. This news represents an important step towards the commercial release of the product.

REGULATORY CE MARK
View Analyst & Ambassador Comments
Go to original news
Nov 07,2018

LifeScan Unveils New Name and Branding for the LifeScan Diabetes Institute

LifeScan, a world leader in blood glucose monitoring, today announced a new name and branding for the LifeScan Diabetes Institute, previously the Johnson & Johnson Diabetes Institute, to reflect LifeScan’s new ownership. As previously announced, Platinum Equity, a leading private investment firm, completed the acquisition of LifeScan and the Institute from Johnson & Johnson on October 2, 2018.

View Analyst & Ambassador Comments
Go to original news
Nov 07,2018

Insulet Collaborates with Samsung to Deliver Galaxy Smartphone-Controlled Insulin Pump Delivery System

Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced it is collaborating with Samsung Electronics America, Inc. for a Samsung Galaxy smartphone-controlled Omnipod System. Once approved, the system will be the first device providing consumers the ability to use their personal Galaxy smartphone1 to securely control their insulin pump therapy.

COLLABORATION PARTNERSHIP

#product & service

#mobile app

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Nov 07,2018

Brighter receives SEK 0.8 M through exercise of warrants.

The exercise period for Brighter’s warrants of series TO3 is now completed. The company thereby strengthens its financing with SEK 837 628, representing 209 407 new shares and votes.

FUNDING VENTURE ROUND
View Analyst & Ambassador Comments
Go to original news
Nov 08,2018

STUDY PRESENTED AT DIABETES TECHNOLOGY MEETING SHOWING THAT USAGE OF CONTOUR®DIABETES APP MAY REDUCE THE CHANCE OF HYPOGLYCEMIC AND HYPERGLYCEMIC EVENTS IN PEOPLE WITH DIABETES

The study was presented today as a poster at the Diabetes Technology Meeting in Bethesda, Maryland by Andreas Stuhr, M.D., Head of Global Medical Affairs and lead author. It examined the impact of usage of the CONTOUR®DIABETES app on the likelihood of hypo- and hyperglycemic events. It also assessed testing frequency in people with diabetes for the first 30 days and after 180 days of app use. The study found that app use for more than 180 days significantly decreased both the likelihood of experiencing at least one hypoglycemic event ≤50 mg/dL (odds ratio 2.47) and the likelihood of experiencing at least one hyperglycemic event >250 mg/dL (odds ratio1.56).

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Nov 08,2018

Nemaura Medical Inc. Reports Second Quarter 2018 Financial Results

The Company’s comprehensive loss was $1,177,758 for the quarter ending September 2018, an increase of $944,036 for the same quarter in 2017, while Research and development expenses increased to $622,282 for the quarter ending September 2018, an increase of $413,195 for the same quarter in 2017.

View Analyst & Ambassador Comments
Go to original news
Nov 08,2018

Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present at the following upcoming investor conferences: Stifel 2018 Healthcare Conference on Tuesday, November 13, 2018 in New York City at 2:00 p.m. Eastern Time (11:00 a.m. Pacific Time), Credit Suisse 27th Annual Healthcare Conference on Wednesday, November 14, 2018 in Scottsdale, AZ, at 12:20 p.m. Eastern Time (9:20 a.m. Pacific Time), Canaccord Genuity Medical Technologies & Diagnostics Forum on Thursday, November 15, 2018 in New York City at 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time), and Piper Jaffray 30th Annual Healthcare Conference onWednesday, November 28, 2018 in New York City at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time).

View Analyst & Ambassador Comments
Go to original news
Nov 08,2018

Senseonics Holdings, Inc. Reports Third Quarter 2018 Financial Results

Senseonics Holding's third quarter revenue was reported as $5.2 million, compared to $3.6 million for the second quarter of 2018 and $2.1 million for the third quarter of 2017.

View Analyst & Ambassador Comments
Go to original news
Nov 12,2018

Tandem Diabetes Care Honored in San Diego 2018 Top Workplaces Awards From San Diego Union-Tribune

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced it has been named a top workplace in San Diego by The San Diego Union-Tribune and awarded a “Future Forward” 2018 Top Workplaces honor.

View Analyst & Ambassador Comments
Go to original news
Nov 12,2018

Nemaura Medical to Present at the Stifel 2018 Healthcare Conference

Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible continuous glucose monitor (CGM) for use by people with diabetes and pre-diabetics, today announced that Chief Business Officer, Bashir Timol, will be presenting at the Stifel 2018 Healthcare Conference on Tuesday, November 13, 2018 in New York.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES